Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
AIDS Malignancy Consortium
University of Nebraska
University of Nebraska
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Stanford University
Targazyme, Inc.
University of Kentucky